Cite
HARVARD Citation
Im, D. et al. (2019). Conformational restriction of a type II FMS inhibitor leading to discovery of 5-methyl-N-(2-aryl-1H-benzo[d]imidazo-5-yl)isoxazole-4-carboxamide analogues as selective FLT3 inhibitors. Journal of enzyme inhibition and medicinal chemistry. pp. 1716-1721. [Online].